CoChat

miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2

Open access
QIU, TIANZHU, ZHOU, LI, WANG, TONGSHAN, XU, JING, WANG, JIAN, CHEN, WENJIAO, ZHOU, XIN, HUANG, ZEBO, ZHU, WEI, SHU, YONGQIAN, LIU, PING · 2013 · International Journal of Molecular Medicine
Cited by 85

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Drug resistance is one of the leading causes of chemotherapy failure in cancer treatment. MicroRNAs (miRNAs or miRs) are short non-coding RNA molecules that post-transcriptionally regulate gene expression and play a critical role in diverse biological processes. In this study, we report that miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin. The expression of miR-503 was decreased in the cisplatin-resistant non-small cell lung cancer cells, A549/CDDP, compared with the parental A549 cells. The overexpression of miR-503 sensitized the A549/CDDP cells to cisplatin, whereas the inhibition of miR-503 in the A549 cells increased resistance to cisplatin. Mechanistically, miR-503 specifically targeted Bcl-2, an anti-apoptotic protein upregulated in the A549/CDDP cells. The ectopic expression of miR-503 reduced the Bcl-2 protein level and sensitized the A549/CDDP cells to cisplatin-induced apoptosis. Taken together, our results suggest that miR-503 regulates cell apoptosis, at least in part by targeting Bcl-2, and thus modulates the resistance of non-small cell lung cancer cells to cisplatin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/ijmm.2013.1439

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 85

Metadata

Authors
QIU, T., ZHOU, L., WANG, T., XU, J., WANG, J., CHEN, W., ZHOU, X., HUANG, Z., ZHU, W., SHU, Y., & LIU, P.
Venue
International Journal of Molecular Medicine
Published
2013-07-12
Volume
32
Issue
3
Pages
593-598
ISSN
  • 1107-3756 (ISSN-L)
  • 1791-244X
OpenAlex
W2151571608
Cited by
85
References
6
FWCI
3.83
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. https://app.cochat.ai/papers/10.3892/ijmm.2013.1439
The paper
QIU, T., ZHOU, L., WANG, T., XU, J., WANG, J., CHEN, W., ZHOU, X., HUANG, Z., ZHU, W., SHU, Y., & LIU, P. (2013). miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2013.1439

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.